Ascent Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.47M | Buy |
49,324
+17,016
| +53% | +$1.89M | 0.21% | 98 |
|
|
2025
Q1 | $3.62M | Buy |
32,308
+11,200
| +53% | +$1.25M | 0.16% | 145 |
|
|
2024
Q4 | $1.95M | Buy |
21,108
+4,435
| +27% | +$410K | 0.15% | 175 |
|
|
2024
Q3 | $1.4M | Buy |
16,673
+3,813
| +30% | +$320K | 0.11% | 239 |
|
|
2024
Q2 | $882K | Sell |
12,860
-2,282
| -15% | -$157K | 0.07% | 284 |
|
|
2024
Q1 | $1.11M | Sell |
15,142
-1,421
| -9% | -$104K | 0.1% | 267 |
|
|
2023
Q4 | $1.23M | Sell |
16,563
-25,915
| -61% | -$1.93M | 0.12% | 224 |
|
|
2023
Q3 | $3.19M | Buy |
42,478
+2,555
| +6% | +$192K | 0.35% | 65 |
|
|
2023
Q2 | $3.2M | Sell |
39,923
-1,081
| -3% | -$86.6K | 0.35% | 71 |
|
|
2023
Q1 | $3.4M | Sell |
41,004
-7,133
| -15% | -$592K | 0.36% | 67 |
|
|
2022
Q4 | $4.13M | Buy |
48,137
+2,967
| +7% | +$255K | 0.49% | 46 |
|
|
2022
Q3 | $3.54M | Buy |
45,170
+18,907
| +72% | +$1.48M | 0.43% | 52 |
|
|
2022
Q2 | $1.57M | Buy |
26,263
+13,115
| +100% | +$784K | 0.19% | 164 |
|
|
2022
Q1 | $782K | Buy |
13,148
+6,527
| +99% | +$388K | 0.09% | 246 |
|
|
2021
Q4 | $454K | Buy |
+6,621
| New | +$454K | 0.06% | 309 |
|